Mendaera Secures $73M Series B Funding to Revolutionize Mainstream Medical Procedures with Robotics and AI

Funding:
Mendaera, a Silicon Valley-based healthcare technology company, has secured $73 million in Series B funding led by Threshold Ventures, with participation from Lux Capital, PFM Health Sciences, and Fred Moll (founder of Intuitive Surgical and Auris Health).

Platform Development:
The funding will be used to further develop Mendaera's handheld robotic interventional platform, accelerate AI and connectivity capabilities, and initiate clinical introductions.

Platform Features:
The platform combines robotics, AI, real-time imaging, and virtual connectivity, designed to be accessible across various specialties and sites of service to meet the demand for needle-based interventions.

Goals:
Mendaera aims to enhance patient experience, increase access to high-quality care, reduce overall costs, and improve healthcare provider satisfaction by making advanced technologies more accessible.

Partnerships:
Mendaera has previously acquired Avail Medsystems' telepresence technology and entered a commercial agreement with Butterfly Network, a point-of-care ultrasound company, to boost its virtual connectivity and ultrasound capabilities.

Industry Impact:
The company is pioneering a new category in medical robotics, addressing healthcare provider shortages and rising costs in mainstream medical procedures.